SCHEMBL23458367

SCHEMBL23458367

Cc1cccc2cc(N(C)C)cc(C)c12

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 4/20 0.46
KDM4E B2RXH2 2/20 0.40
MAPT P10636 3/20 0.39
GAA P10253 1/20 0.39
ALDH1A1 P00352 5/20 0.36
TSHR P16473 4/20 0.36
CYP2A6 P11509 2/20 0.35
MEN1 O00255 3/20 0.34
NPC1 O15118 3/20 0.34
RAB9A P51151 3/20 0.34
KMT2A Q03164 3/20 0.34
HSP90AA1 P07900 1/20 0.34
ELANE P08246 1/20 0.34
KDM1A O60341 1/20 0.34
TDP1 Q9NUW8 2/20 0.33
HSD17B10 Q99714 2/20 0.33
NSD2 O96028 1/20 0.33
CASP3 P42574 1/20 0.33
SENP8 Q96LD8 1/20 0.33
SENP7 Q9BQF6 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29862395 1.00 CYP1A2 (0.46) CYP1A2KDM4EMAPTGAAALDH1A1
SCHEMBL24882332 0.79 ALDH1A1 (0.52) CYP1A2KDM4EMAPTGAAALDH1A1
SCHEMBL598921 0.74 CYP1A2 (0.52) CYP1A2KDM4EALDH1A1TSHRCYP2A6
SCHEMBL17383659 0.73 CYP1A2 (0.57) CYP1A2KDM4EGAAALDH1A1TSHR
SCHEMBL29862170 0.73 CYP1A2 (0.57) CYP1A2KDM4EGAAALDH1A1TSHR
SCHEMBL11302593 0.73 TERT (0.48) CYP1A2KDM4EMAPTGAAALDH1A1
SCHEMBL588459 0.72 ALDH1A1 (0.53) CYP1A2KDM4EMAPTGAAALDH1A1
SCHEMBL29353343 0.72 ALDH1A1 (0.53) CYP1A2KDM4EMAPTGAAALDH1A1
SCHEMBL12748865 0.72 CYP1A2 (0.59) CYP1A2KDM4EALDH1A1TSHRCYP2A6
SCHEMBL11714760 0.71 CYP1A2 (0.48) CYP1A2KDM4EMAPTALDH1A1TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12510529-B2 Method for determining authenticity and adulteration of marked petroleum hydrocarbons SICPA HOLDING SA (CH) 2025-12-30 US disclosed
EP-4069806-B1 METHOD OF MARKING A PETROLEUM HYDROCARBON SICPA HOLDING SA (CH) 2025-04-16 EP disclosed
US-20240327736-A1 METHOD OF MARKING A PETROLEUM HYDROCARBON SICPA HOLDING SA (CH) 2024-10-03 US disclosed
US-12031098-B2 Method of marking a petroleum hydrocarbon SICPA HOLDING SA (CH) 2024-07-09 US disclosed
EP-4069807-B1 METHOD FOR DETERMINING AUTHENTICITY AND ADULTERATION OF MARKED PETROLEUM HYDROCARBONS SICPA HOLDING SA (CH) 2023-10-04 EP disclosed
US-20230103579-A1 METHOD FOR DETERMINING AUTHENTICITY AND ADULTERATION OF MARKED PETROLEUM HYDROCARBONS SICPA HOLDING SA (CH) 2023-04-06 US disclosed
US-20230029106-A1 METHOD OF MARKING A PETROLEUM HYDROCARBON SICPA HOLDING SA (CH) 2023-01-26 US disclosed
WO-2021110525-A1 METHOD FOR DETERMINING AUTHENTICITY AND ADULTERATION OF MARKED PETROLEUM HYDROCARBONS SICPA HOLDING SA (CH) 2021-06-10 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12510529-B2 Method for determining authenticity and adulteration of marked petroleum hydrocarbons CYP4A11, CYP11B1, CYP11A1 CYP1A2 57/4885KDM4E 1686/4885MAPT 4817/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.